Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro.
about
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infectionRetrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alphaRetroviral superinfection resistance.Novel Escape Mutants Suggest an Extensive TRIM5α Binding Site Spanning the Entire Outer Surface of the Murine Leukemia Virus Capsid ProteinThe human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationViral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.TRIM5 alpha cytoplasmic bodies are highly dynamic structures.Proteasomal degradation of TRIM5alpha during retrovirus restrictionCooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.Use of a transient assay for studying the genetic determinants of Fv1 restriction.Identification of the regions of Fv1 necessary for murine leukemia virus restriction.Integration of murine leukemia virus DNA depends on mitosisCellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropismCharacterization of producer cell-dependent restriction of murine leukemia virus replicationCharacterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection.Copy number variation and differential expression of a protective endogenous retrovirus in sheep.Posttranslational inhibition of Ty1 retrotransposition by nucleotide excision repair/transcription factor TFIIH subunits Ssl2p and Rad3p.Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infectionA triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2Role of Human TRIM5α in Intrinsic Immunity.Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia.Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcriptionCoordinated disintegration reactions mediated by Moloney murine leukemia virus integrase.Pantropic retroviruses as a transduction tool for sea urchin embryos.A phenotypic host range alteration determines RD114 virus restriction in feline embryonic cellsNecessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag proteinRestriction of foamy viruses by primate Trim5alphaHost restriction factors blocking retroviral replicationCapsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cellsTRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cellsRetroviral capsid determinants of Fv1 NB and NR tropism.Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNASelection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection.Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes.Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection.
P2860
Q24544232-EB6C68D1-DDF2-4499-8E33-B7DBAF94364AQ24561939-F3795BA1-367E-42F9-A2D7-F5F7E7EF3DBFQ24815564-755F4992-75DB-4769-BA00-BC47039CCADDQ27667494-60C6A035-C9D7-444E-9809-A526BAEA616DQ28378949-4AF11637-8DC8-438F-8D1A-588B4B48D641Q28546614-ADC97EBD-97AE-4FF1-98BE-B2C5060EC8C9Q30327614-F925B5AB-E5CD-473D-B448-605B0E054F2CQ30479495-48EB3EB1-A802-4187-836D-21375F2F9131Q33337129-44FCDDE6-ABC0-4DFD-9378-6EADA06D7F54Q33707470-C13825E0-A8A1-4763-A949-8BC9569A463AQ33783464-E150CCEB-2468-401B-9BC3-90D45B39845BQ33809632-AE46D7A7-32FD-48C4-AA77-EE2EC8C8A356Q33851839-6A346812-5680-4F80-8068-E1EFF67FCB40Q34051046-FD4EAF72-7E78-4EB5-809C-509AF69195CFQ34154693-09568FD7-1853-494E-ABF7-843815EAE5EBQ34341128-497F12CC-10C9-458E-9233-6AD33EC15E46Q34350205-60D1222A-CB2B-43D1-A29F-C704FD807D4DQ34388265-842A847D-D004-41CC-B146-0A89DD40E393Q34604117-A077D0F5-46A0-40AA-803B-B7D9F5331130Q35023942-3F762743-BF86-4DBB-B5CB-2FE8CB669234Q35101356-24B68676-CA7C-4C22-B98D-7BB4ED247D53Q35635089-7242A3A5-833A-4073-BC4D-30E92D49FB0AQ35641044-4B6A8D81-4BBE-4810-A2D3-A5ABACDDDC74Q35831267-C0138F6D-60ED-4817-BD16-009978D8A27DQ35831703-1036D282-E293-42BF-A487-BAD9488F5BD5Q35841323-770FD08B-33A4-40F2-8B39-89A4A31B6A3CQ35861172-0D8290BC-6318-456E-81C1-0219CB0589D8Q35861832-6F55CDE6-A57F-425E-8C18-5E66C987FA26Q35887248-864B8B81-AA18-40DF-B518-FF55C80050D5Q36651072-4D5A2B98-EDED-47B5-9D64-37471CA25FCEQ36653886-4FC41878-2FE6-43BD-9465-7773F1EAD93DQ36673325-AE483322-89A4-473B-BF4E-4826AE1C9076Q36687748-80D9A847-BAD6-4684-96A6-4AE74D36C320Q36943400-9AB48472-FB71-4430-B516-7210DECE4277Q37416225-689D94EA-E82D-4019-94D6-7F5F6B7F35E3Q37492696-99EC974E-F83C-450E-A073-C213EAAEB3D0Q37583411-D1611B24-EEC1-475A-8126-0831A32E8E87Q37583499-B9AE02AE-18A0-402E-8D69-542911B0E7BCQ38150610-2E5CF10B-6F8B-4E81-9AF4-BDA539DE44EEQ38611580-20ED74AF-C50F-4E4C-9D31-100A0E2DB328
P2860
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Fv-1 restriction and its effec ...... egration in vivo and in vitro.
@en
type
label
Fv-1 restriction and its effec ...... egration in vivo and in vitro.
@en
prefLabel
Fv-1 restriction and its effec ...... egration in vivo and in vitro.
@en
P2860
P1433
P1476
Fv-1 restriction and its effec ...... egration in vivo and in vitro.
@en
P2093
Pryciak PM
P2860
P304
P407
P577
1992-10-01T00:00:00Z